Dr. David Ulmert Awarded Grant to Advance Targeted Therapy for Osteosarcoma
June 18, 2025
June 18, 2025
LOS ANGELES, California, June 18 -- The UCLA Health issued the following news release:
* * *
Dr. David Ulmert awarded grant to advance targeted therapy for osteosarcoma
Dr. David Ulmert, associate professor of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA, has been selected to receive the Hero Award from MIB Agents, a pediatric osteosarcoma nonprofit. The award, part of the organization's OutSmarting Osteosarcoma gra . . .
* * *
Dr. David Ulmert awarded grant to advance targeted therapy for osteosarcoma
Dr. David Ulmert, associate professor of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA, has been selected to receive the Hero Award from MIB Agents, a pediatric osteosarcoma nonprofit. The award, part of the organization's OutSmarting Osteosarcoma gra . . .